SCHEMBL7652701

SCHEMBL7652701

CCNS(=O)(=O)c1cc2cc(P(=O)(O)O)c(=O)[nH]c2cc1Cl

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.37
ALDH1A1 P00352 3/20 0.37
GAA P10253 1/20 0.37
GRIN2D O15399 3/20 0.37
GRIN3B O60391 3/20 0.37
GRIN1 Q05586 3/20 0.37
GRIN2A Q12879 3/20 0.37
GRIN2B Q13224 3/20 0.37
GRIN2C Q14957 3/20 0.37
GRIN3A Q8TCU5 3/20 0.37
ATM Q13315 1/20 0.35
GRIA1 P42261 2/20 0.35
GRIA2 P42262 2/20 0.35
GRIA3 P42263 2/20 0.35
GRIA4 P48058 2/20 0.35
HSD17B10 Q99714 4/20 0.34
HPGD P15428 3/20 0.34
TSHR P16473 1/20 0.33
POLB P06746 1/20 0.33
GRIK1 P39086 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6939707 0.91 POLB (0.36) KDM4EALDH1A1GRIN2DGRIN3BGRIN1
SCHEMBL7651600 0.89 CA12 (0.38) KDM4EALDH1A1GAAGRIN2DGRIN3B
SCHEMBL6939746 0.87 GRIN2D (0.37) KDM4EALDH1A1GRIN2DGRIN3BGRIN1
SCHEMBL7651540 0.86 GAA (0.41) GAATSHRPOLBMAPT
SCHEMBL7648730 0.85 GRIN2D (0.35) KDM4EALDH1A1GRIN2DGRIN3BGRIN1
SCHEMBL7647652 0.85 KDM4E (0.38) KDM4EALDH1A1GAAGRIN2DGRIN3B
Bromide SCHEMBL6937193 0.85 GAA (0.40) GAATSHRPOLBMAPT
SCHEMBL7647655 0.85 ATM (0.34) KDM4EALDH1A1GAAGRIN2DGRIN3B
SCHEMBL7648786 0.84 GRIN1 (0.35) KDM4EALDH1A1GRIN2DGRIN3BGRIN1
SCHEMBL7652655 0.84 GSTO1 (0.37) KDM4EALDH1A1GRIN2DGRIN3BGRIN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6486143-B2 NERVOUS SYSTEM DISORDERS; PSYCHOLOGICAL DISORDERS LES LABORATOIRES SERVIER (FR) 2002-11-26 US disclosed
US-20010031746-A1 6-amino- or 6-hydrazino-sulphonyl-3-quinolynyl-phosphonic acid compounds LES LABORATOIRES SERVIER (FR) 2001-10-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010031746-A1 6-amino- or 6-hydrazino-sulphonyl-3-quinolynyl-phosphonic acid compounds CA6, P2RY6, FPR3 KDM4E 4419/4885ALDH1A1 1221/4885GAA 1197/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.